- Home
- SYBT vs BCRX Comparison
SYBT vs BCRX Comparison
Compare SYBT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYBT | BCRX |
|---|---|---|
| Founded | 1904 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 2009 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SYBT | BCRX |
|---|---|---|
| Price | $72.39 | $9.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $76.00 | $20.82 |
| AVG Volume (30 Days) | 137.9K | ★ 3.8M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.81% | N/A |
| EPS Growth | 22.11 | ★ 381.40 |
| EPS | ★ 4.75 | 1.21 |
| Revenue | $23,406,000.00 | ★ $25,186,000.00 |
| Revenue This Year | $17.31 | N/A |
| Revenue Next Year | $9.32 | $12.55 |
| P/E Ratio | $14.95 | ★ $7.41 |
| Revenue Growth | ★ 3.37 | N/A |
| 52 Week Low | $61.51 | $6.00 |
| 52 Week High | $83.83 | $11.31 |
Technical Indicators
Market Signals| Indicator | SYBT | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.93 | 52.27 |
| Support Level | $72.29 | $7.99 |
| Resistance Level | $73.79 | $10.15 |
| Average True Range (ATR) | 1.82 | 0.36 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 64.64 | 54.55 |
Price Performance
Historical ComparisonAbout SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.